MedTrace Logo

Molecular Analysis of Patients With Neuromuscular Disease

NCT00390104 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2023-04-24

No results posted yet for this study

Summary

The purpose of this study is to identify new genes responsible for neuromuscular disorders and study muscle tissue of patient with known neuromuscular disease, as well as their family members. We are interested in recruiting many types of neuromuscular disease including; Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), and limb-girdle muscle dystrophy (LGMD). There are still many patients diagnosed with muscular dystrophy with no causative gene implicated in their disease. Using molecular genetics to unravel basis of these neuromuscular disorders will lead to more accurate diagnosis/prognosis of these disorders which will lead to potential therapies.

Conditions

  • Neuromuscular; Disorder, Hereditary
  • Duchenne/Becker Muscular Dystrophy
  • Limb-girdle Muscular Dystrophy

Sponsors & Collaborators

Principal Investigators

  • Louis M Kunkel, PhD · Boston Children's Hospital/Harvard Medical School

Eligibility

Min Age
1 Week
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-01-31
Primary Completion
2026-12-31
Completion
2027-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00390104 on ClinicalTrials.gov